Metoprolol tartrate

Metoprolol Tartrate is the tartrate salt form of metoprolol, a cardioselective competitive beta-1 adrenergic receptor antagonist with antihypertensive properties and devoid of intrinsic sympathomimetic activity. Metoprolol tartrate antagonizes beta 1-adrenergic receptors in the myocardium, thereby reducing the rate and force of myocardial contraction, and consequently a diminished cardiac output. This agent may also reduce the secretion of renin with subsequent reduction in levels of angiotensin II thus decreasing sympathetic activation, including vasoconstriction, aldosterone secretion. It is grouped under the following drug class(es): Antianginals and Beta blockers. Its therapeutic use is listed as cardiovascular and migraine preventive agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Betaloc, Lopresor, Selopral, Prelis and Arbralene. Its PubChem CID is 441308.

CAS No 56392-17-7
Molecular Formula C34H56N2O12
Molecular Weight 684.80 g/mol
Synonyms (2R,3R)-2,3-dihydroxybutanedioic acid;1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol

Frequently Asked Questions